Journal
NANOSCALE ADVANCES
Volume 5, Issue 8, Pages 2132-2166Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/d2na00930g
Keywords
-
Ask authors/readers for more resources
SERS plays a crucial role in biosensing innovation, but faces challenges in its application to the biomedical field. Solutions involve enhancing substrate design and improving spectral collection set-up.
In the wake of a global, heightened interest towards biomarker and disease detection prompted by the SARS-CoV-2 pandemic, surface enhanced Raman spectroscopy (SERS) positions itself again at the forefront of biosensing innovation. But is it ready to move from the laboratory to the clinic? This review presents the challenges associated with the application of SERS to the biomedical field, and thus, to the use of excitation sources in the near infrared, where biological windows allow for cell and through-tissue measurements. Two main tackling strategies will be discussed: (1) acting on the design of the enhancing substrate, which includes manipulation of nanoparticle shape, material, and supramolecular architecture, and (2) acting on the spectral collection set-up. A final perspective highlights the upcoming scientific and technological bets that need to be won in order for SERS to stably transition from benchtop to bedside.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available